Early View - DiabetesontheNet

This site is intended for healthcare professionals only

Diabetes Digest

Early View

Filter:

Overweight and obesity in people with type 1 diabetes

Daniel Flanagan reviews the long-term effects of increasing obesity rates in people with type 1 diabetes and asks what clinicians can do.

Early View

Prevalence of obesity and CKD in people with type 1 diabetes

Obesity rates are high and rising in people with type 1 diabetes and are associated with a higher risk of CKD versus the general population.

Early View

CGM initiation within 1 year of diagnosis improves long-term glycaemic control

Initiating CGM early may set a better glycaemic trajectory, with effects on long-term diabetes outcomes.

Early View

Flexible, patient-controlled visits to type 1 diabetes clinics

DiabetesFlex trial: A more flexible model for routine clinic visits is safe and reduces the burden for people with type 1 diabetes.

Early View

Efficacy and safety of SGLT2 inhibitors in a real-world type 1 diabetes cohort

Retrospective study shows SGLT2 inhibitors are effective as an adjunct to insulin, although DKA remains a concern.

Early View

Delivering care at a distance for people with diabetes

Daniel Flanagan asks what is needed for diabetes services to successfully transition to a hybrid model of remote and face-to-face care.

Early View

Remote care and insulin pump education: Current provision and healthcare professionals’ experience

Pump starts and renewals have been reduced in the pandemic as care delivery went primarily remote.

Early View

Outcomes of funded CGM access in young people with type 1 diabetes in Australia

Universal funding of CGM results in rapid uptake and sustained use, as well as improvements in glycaemic control and clinical outcomes.

Early View

Using CGM to predict progression to type 1 diabetes in children with positive islet autoantibodies

A cut-off of >10% of time above 7.8 mmol/L is an accurate predictor of progressing from islet autoimmunity to clinical type 1 diabetes.

Early View

Accuracy and tolerability of alternative sites for flash glucose monitor sensor placement

Are the chest and the lower back clinically acceptable sites for flash glucose sensor placement?

Early View

Continuing versus discontinuing CGM in people with type 2 diabetes

Discontinuing CGM results in a loss of nearly half of the improvements in time in range that are achieved during CGM use.

Early View

Combining flash glucose monitoring with an automated bolus calculator

Does combining these two technologies improve HbA_1c?

Early View

Insulin strategies for dietary fat and protein in type 1 diabetes

Systematic review evaluates the efficacy of various insulin dosing strategies to adjust for the fat and protein content of meals.

Early View

The challenge of multiple daily insulin injections

Amid all the complexities of insulin dosing, Daniel Flanagan wonders whether clinicians are overlooking the basics of insulin administration and timing.

Early View

Prevalence and effects of missed and mistimed insulin doses

Missed and mistimed insulin doses are common in people with type 1 and type 2 diabetes.

Early View

Incidence and prevalence of type 1 diabetes varies widely across the globe

With most data coming from northern Europe, greater effort should be made to quantify the burden of type 1 diabetes worldwide.

Early View

Insulin degludec in people prone to nocturnal severe hypoglycaemia

In results consistent with clinical trials, degludec reduces hypoglycaemia compared with glargine in this at-risk group.

Early View

A prediction model for individual glycaemic responses to food

Using clinical, personal, dietary and even microbial data to predict an individual's postprandial glycaemic response.

Early View

LATEST ARTICLES

Type 2 diabetes: Reframing the first stage of care

A low-carbohydrate weight-loss intervention: 8-year practice service evaluation

Effect of weight change on remission in people with newly diagnosed type 2 diabetes

Healthy versus unhealthy plant-based diets: How do they affect type 2 diabetes risk?

Cumulative glycaemic exposure and cardiovascular risk

Look AHEAD: Intensive lifestyle intervention less effective in those with higher HbA1c

New kids on the block: Friend or Foe?

For the latest news and articles

Sign up to all DiabetesontheNet journals

Follow us for all the latest news and updates in diabetes.

Resources

Journals

Useful information

© Copyright Omniamed Communications. All Rights Reserved
108 Cannon Street, London, EC4N 6EU. Registered in the United Kingdom

;